Agilent Companion Diagnostic Assay PD-L1 IHC 28-8 pharmDx Receives European IVDR Certification [Yahoo! Finance]
Agilent Technologies, Inc. (A)
Last agilent technologies, inc. earnings: 2/18 04:05 pm
Check Earnings Report
US:NYSE Investor Relations:
investor.agilent.com
Company Research
Source: Yahoo! Finance
In Vitro Diagnostic Regulation (IVDR) certification for PD-L1 IHC 28-8 pharmDx (Code SK005). This CDx assay has previously been CE-IVD–marked for sales in the European Union and is now certified in accordance with the new EU Regulation for in vitro diagnostic medical devices (IVDR) . PD-L1 IHC 28-8 pharmDx is approved for exclusive use with the Agilent Autostainer Link 48 advanced staining solution. Agilent's PD-L1 IHC 28-8 pharmDx (Code SK005) provides clinically relevant information about PD-L1 expression – a critical biomarker for potential response to therapies containing anti-PD-1 antibodies such as OPDIVO® (nivolumab) which has demonstrated therapeutic value across growing list of cancer types and Opdualag TM (nivolumab and relatimab). PD-L1 IHC 28-8 pharmDx (Code SK005) has received European IVDR certification for nine cancer indications, including five companion diagnostic indications; non-small cell lung cancer (NSCLC), muscle invasive urothelial carcinoma (MIUC), melanom
Show less
Read more
Impact Snapshot
Event Time:
A
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
A alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
A alerts
High impacting Agilent Technologies, Inc. news events
Weekly update
A roundup of the hottest topics
A
News
- Optical Genome Mapping Industry Research (2018-2033) Featuring Profiles of Agilent Technologies, Illumina, PerkinElmer Genomics, Bio-Rad Labs, Qiagen and Other Leading Players [Yahoo! Finance]Yahoo! Finance
- Agilent Companion Diagnostic Assay PD-L1 IHC 28-8 pharmDx Receives European IVDR CertificationBusiness Wire
- Whole Genome Sequencing Market Analysis and Forecast 2024-2034: Cost of Sequencing a Human Genome has Decreased from about $3 Billion at the end of the Human Genome Project in 2003 to $600 in 2024 [Yahoo! Finance]Yahoo! Finance
- Agilent Gains 5% in a Month: Should You Buy, Sell or Hold the Stock? [Yahoo! Finance]Yahoo! Finance
- Agilent Technologies, Inc. (NYSE: A) had its price target lowered by analysts at Wells Fargo & Company from $157.00 to $155.00. They now have an "overweight" rating on the stock.MarketBeat
A
Earnings
- 11/25/24 - Beat
A
Sec Filings
- 12/3/24 - Form 4
- 12/2/24 - Form 4
- 12/2/24 - Form 4
- A's page on the SEC website